The CEO Behind Ozempic, Wegovy and Europe's Most Valuable Company
#Ozempic #Wegovy #obesity #diabetes #weightloss #healthcare #pharmaceuticals #novonordisk #drugs #leadership #CEO Novo Nordisk is Europe’s most valuable company with booming demand for its blockbuster diabetes and obesity drugs, Ozempic and Wegovy. They’re revolutionizing the weight loss drug industry, with some analysts predicting it could be worth up to $150 billion a year. Social media like TikTok and celebrities have helped their popularity soar. But it's not without controversy, including possible side effects and high prices. On the latest episode of Leaders with Lacqua, Francine Lacqua travels to the firm’s headquarters in Copenhagen, Denmark. She speaks to chief executive, Lars Fruergaard Jørgensen, about how he’s navigating the company’s meteoric rise and the sweeping changes its products could bring across a range of industries. 00:00 - Intro 02:00 - Novo Nordisk CEO Lars Fruergaard Jørgensen on Ozempic, Wegovy, diabetes, obesity 05:00 - Novo Nordisk CEO Lars Fruergaard Jørgensen on eating habits, social media, celebrities 08:50 - Novo Nordisk CEO Lars Fruergaard Jørgensen on prices, US investments, acquisitions 15:00 - Novo Nordisk CEO Lars Fruergaard Jørgensen on Covid, pandemic, vaccines 17:10 - Novo Nordisk CEO Lars Fruergaard Jørgensen on CEO leadership, corporate culture, advice #bloomberg #leaderswithlacqua #francinelacqua -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9 Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more. Connect with Bloomberg Television on: X: / bloombergtv Facebook: / bloombergtelevision Instagram: / bloombergtv Connect with Bloomberg Business on: X: / business Facebook: / bloombergbusiness Instagram: / bloombergbusiness TikTok: https://www.tiktok.com/@bloombergbusi... Reddit: / bloomberg LinkedIn: / bloomberg-news More from Bloomberg: Bloomberg Radio: / bloombergradio Bloomberg Surveillance: / bsurveillance Bloomberg Politics: / bpolitics Bloomberg Originals: / bbgoriginals Watch more on YouTube: Bloomberg Technology: / @bloombergtechnology Bloomberg Originals: / @business Bloomberg Quicktake: / @bloombergquicktake Bloomberg Espanol: / @bloomberg_espanol Bloomberg Podcasts: / @bloombergpodcasts

Johann Hari: They’re Lying To You About The Side Effects Of Ozempic!

How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company

Lars Fruergaard Jørgensen - Novo Nordisk | Investment Conference 2025

The David Rubenstein Show: Eli Lilly CEO Dave Ricks

What Happens When You Stop ‘Skinny Jabs’? | BBC News

AI Bubble Will Burst Eventually Says Bridgewater's Ray Dalio

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

The Story of GLP-1: Episode 1 - "A diabetes doctor’s dream"

Rolls-Royce CEO Tufan Erginbilgiç Shares His Turnaround Playbook

You're Being Lied To About Ozempic | Truth Complex | Business Insider

GLP-1s Are a Lot Weirder Than Anyone Thought | The Ezra Klein Show

Novo Nordisk CEO Lars Jorgensen testifies before Senate on weight loss drugs pricing — 9/24/24

Why Only 3 Companies Make America's Insulin

When JPMorgan CEO Jamie Dimon Speaks, the World Listens | The Circuit

Stop Guessing About the Wegovy Pill: A Prescriber Explains All!

CEO DIALOGUE #35 - Lars Fruergaard Jørgensen, Novo Nordisk

How Do Ozempic, Mounjaro & Other GPL-1 Agonists Work? | Dr. Zachary Knight & Dr. Andrew Huberman

10 Ozempic Diet Mistakes That RUIN Your Weight Loss (AVOID These Foods)

